Your browser doesn't support javascript.
loading
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance.
Engel, Christoph; Fischer, Christine; Zachariae, Silke; Bucksch, Karolin; Rhiem, Kerstin; Giesecke, Jutta; Herold, Natalie; Wappenschmidt, Barbara; Hübbel, Verena; Maringa, Monika; Reichstein-Gnielinski, Simone; Hahnen, Eric; Bartram, Claus R; Dikow, Nicola; Schott, Sarah; Speiser, Dorothee; Horn, Denise; Fallenberg, Eva M; Kiechle, Marion; Quante, Anne S; Vesper, Anne-Sophie; Fehm, Tanja; Mundhenke, Christoph; Arnold, Norbert; Leinert, Elena; Just, Walter; Siebers-Renelt, Ulrike; Weigel, Stefanie; Gehrig, Andrea; Wöckel, Achim; Schlegelberger, Brigitte; Pertschy, Stefanie; Kast, Karin; Wimberger, Pauline; Briest, Susanne; Loeffler, Markus; Bick, Ulrich; Schmutzler, Rita K.
  • Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Fischer C; Institute of Human Genetics, Ruprecht-Karls University, Heidelberg, Germany.
  • Zachariae S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Bucksch K; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Rhiem K; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Giesecke J; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Herold N; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Hübbel V; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Maringa M; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Reichstein-Gnielinski S; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Hahnen E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Bartram CR; Institute of Human Genetics, Ruprecht-Karls University, Heidelberg, Germany.
  • Dikow N; Institute of Human Genetics, Ruprecht-Karls University, Heidelberg, Germany.
  • Schott S; Department of Gynaecology, Ruprecht-Karls University, Heidelberg, Germany.
  • Speiser D; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Horn D; Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Fallenberg EM; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Kiechle M; Department of Gynecology and Obstetrics, University Hospital Rechts der Isar, Technical University Munich, Munich, Germany.
  • Quante AS; Department of Gynecology and Obstetrics, University Hospital Rechts der Isar, Technical University Munich, Munich, Germany.
  • Vesper AS; Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
  • Fehm T; Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
  • Mundhenke C; Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.
  • Arnold N; Department of Gynecology and Obstetrics, Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.
  • Leinert E; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Just W; Institute of Human Genetics, University of Ulm, Ulm, Germany.
  • Siebers-Renelt U; Institut für Humangenetik, Universitätsklinikum Münster, Münster, Germany.
  • Weigel S; Institute of Clinical Radiology, Medical Faculty, University of Muenster, University Hospital Muenster, Muenster, Germany.
  • Gehrig A; Institute of Human Genetics, Würzburg University, Würzburg, Germany.
  • Wöckel A; Department of Obstetrics and Gynecology, Würzburg University Hospital, Würzburg, Germany.
  • Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Pertschy S; Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
  • Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Wimberger P; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Briest S; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Loeffler M; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bick U; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Schmutzler RK; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Int J Cancer ; 146(4): 999-1009, 2020 02 15.
Article en En | MEDLINE | ID: mdl-31081934
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteína BRCA1 / Predisposición Genética a la Enfermedad / Proteína BRCA2 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article